New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
12:08 EDTMSPD, BIDU, PBY, GERN, YOKU, BIG, GALE, UEPS, SINA, DRIOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday in a lackluster trading session, with the Dow the leader and the Nasdaq the laggard. In the latest chapter of the unfolding fiscal cliff drama, President Obama’s administration rejected a Republican plan that did not include higher tax rates for wealthy Americans. The next batch of cliff headlines may come from an interview that President Obama has scheduled for this afternoon on Bloomberg Television... ECONOMIC EVENTS: No major economic data was released in the U.S. Internationally, the Reserve Bank of Australia cut its key benchmark interest rate to 3.00% from 3.25%, as expected, and the Bank of Canada maintained its target for its overnight rate at 1%... COMPANY NEWS: Darden Restaurants (DRI), the parent company of Olive Garden, Red Lobster and LongHorn Steakhouse, warned its profit for the current quarter and the year may fall well short of analyst expectations. The company, whose shares tumbled nearly 10% after the outlook announcement, blamed failed promotions and negative press on its tests to limit rising health care costs for its under performance... Among companies reporting quarterly results, Big Lots (BIG) advanced 9.7% while Pep Boys (PBY) declined 13.7%... A number of U.S.-listed Chinese companies traded lower after the SEC charged the Chinese subsidiaries of the four major U.S. accounting firms with refusing to cooperate in investigations of alleged accounting fraud at Chinese companies. Shares of Sina (SINA), Youku Tudou (YOKU) and Baidu (BIDU) were among those declining following the news... MAJOR MOVERS: Among the notable gainers were Galena Biopharma (GALE), up almost 10% after signing a commercialization partnership for its NeuVax drug with Teva (TEVA), and Mindspeed Technologies (MSPD), up 7% after raising its Q1 revenue view. Among the noteworthy losers was Net 1 UEPS (UEPS), which plunged 56% after disclosing the DOJ and FBI are investigating the company for potential violations of the Foreign Corrupt Practices Act. Also lower were shares of Geron (GERN), down 25% after it discontinued development of a treatment for brain cancer, announced job cuts and said its CFO is leaving the company to pursue other opportunities... INDICES: Near noon, the Dow was up 15.36, or 0.12%, to 12,980.96; the Nasdaq was down 11.77, or 0.39%, to 2,990.43; and the S&P 500 was down 1.88, or 0.13%, to 1,407.58.
News For DRI;BIG;PBY;SINA;YOKU;BIDU;UEPS;GERN;MSPD;GALE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2015
07:26 EDTGALEGalena completes over-enrollment of NeuVax Phase 3 PRESENT clinical trial
Galena Biopharma announced the completion of enrollment in the NeuVax Phase 3 PRESENT, or Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment, clinical trial. NeuVax is a first-in-class, HER2-directed cancer immunotherapy under evaluation to prevent breast cancer recurrence after standard of care treatment in the adjuvant setting. As anticipated, Galena over-enrolled the trial by 7.7% with a total of 758 patients now in the intent-to-treat, or ITT, population. The protocol for the PRESENT trial, being conducted under an FDA approved Special Protocol Assessment, or SPA, called for 700 patients; and, the company expects this higher number of ITT patients will increase the confidence in both the timing and quality of the statistics and the final outcome of the trial. The primary endpoint is currently expected to be reached in 2018, after the last patient dosed reaches her 36th month of treatment, or a total of 141 events occur, whichever comes later.
April 13, 2015
16:36 EDTPBYPep Boys CEO says seeing turn around in business
Subscribe for More Information
16:35 EDTPBYPep Boys reports Q4 EPS (50c) with items, consensus 3c
Subscribe for More Information
16:21 EDTSINAOn The Fly: Top stock stories for Monday
Subscribe for More Information
15:38 EDTPBYNotable companies reporting after market close
Subscribe for More Information
13:26 EDTSINAOn The Fly: Top stock stories at midday
Stocks on Wall Street were mixed at midday, with the Dow and S&P 500 slightly lower and the Nasdaq clinging to a narrow gain. The broader market opened in positive territory and the averages moved in a narrow trading range during the morning. The Nasdaq has been the strongest of the indices since the open, though early gains from Apple (AAPL) and Qualcomm (QCOM) had evaporated by near midday, taking a bite out of the gains the index had been seeing earlier in the session. ECONOMIC EVENTS: In the U.S., no major economic data was released. In China, export sales unexpectedly contracted 15% in March, while imports shrank 12.7% last month from a year ago. The March fall in imports was in line with forecasts, unlike the one for exports, which were expected to rise 12%. COMPANY NEWS: Activist investor Jana Partners is putting pressure on Qualcomm to increase stock buybacks and take other actions to increase shareholder value, including an exploration of spinning off its chip unit from its patent-licensing unit. In response to statements made by JANA, Qualcomm noted that it recently increased its stock repurchase authorization to $15B and repeated that it plans to repurchase $10B of common stock within one year. Barry Rosenstein of JANA Partners, while speaking on CNBC, said Qualcomm should buy back $15B of its shares over the next six months, before the company undertakes strategic actions that could move the stock higher... Apple shares were rising early in the trading day but had given up their gains by midday. Pre-orders of its new Apple Watch started Friday. The company did not release any sales figures for the first weekend, but research firm Slice Intelligence estimated that nearly one million customers in the U.S. preordered the device on the first day it was available. MAJOR MOVERS: Among the notable gainers were Alamos Gold (AGI), which rose 6%, and AuRico Gold (AUQ), which rose 7%, after the companies announced an agreement to combine via "a merger of equals" with a transaction equity value of about $1.5B. Upon completion of the deal, former Alamos and AuRico shareholders will each own approximately 50% of the new Alamos Gold and a new company, to be named AuRico Metals, will be created to hold AuRico's Kemess project and some other assets. The newly formed company will own a 4.9% equity interest in the spinoff and the remaining "SpinCo" shares will be distributed 50% each to former Alamos and AuRico shareholders. Also higher was Builders FirstSource (BLDR), which gained 65% after announcing that it has entered into an agreement to acquire ProBuild Holdings in an all-cash transaction valued at about $1.63B. Among the noteworthy losers was Basic Energy (BAS), which fell 8% after Raymond James downgraded the stock to Market Perform based on valuation, substantial pricing pressure, and industry overcapacity. Also lower were U.S.-listed shares of Sina (SINA), which dropped 5% after the Financial Times reported that China's government has warned that it will shut down the company's service if it does not "improve censorship." INDEXES: Near midday, the Dow was down 19.08, or 0.11%, to 18,038.57, the Nasdaq was up 7.93, or 0.16%, to 5,003.91, and the S&P 500 was down 3.04, or 0.14%, to 2,099.02.
09:38 EDTSINASINA trades lower after Beijing warns on insufficient censorship
Subscribe for More Information
09:20 EDTSINAOn The Fly: Pre-market Movers
HIGHER: Builders FirstSource (BLDR), up 54.35% after acquiring ProBuild in all-cash transaction... Arrowhead (ARWR), up 14.3% after being cleared to proceed with multiple dose Phase 2b study of ARC-520... Oramed Pharmaceuticals (ORMP), up 6.9% after enrolling first patient in glucose clamp study for oral insulin... Clovis Oncology (CLVS), up 8.2% after being upgraded to Buy from Neutral at Goldman... Quantum (QTM), up 3.2% after announcing go-to-market partnership with Dot Hill Systems (HILL)... Netflix (NFLX), up 3.4% after being upgraded to Buy from Neutral at UBS... Apple (AAPL), up just under 1% following reports of Apple Watch orders. LOWER: Sina (SINA), down 3% following a report from the Financial Times that China may shut down the company if censorship doesn't improve... Ruckus Wireless (RKUS), down 2.9% after being downgraded to Buy from Conviction Buy at Goldman... Allot Communications (ALLT), down 2.7% after being downgraded to Hold from Buy at Needham.
06:29 EDTSINAChina may shut down Sina if censorship doesn't improve, Financial Times says
Subscribe for More Information
April 10, 2015
10:56 EDTBIDUStocks with call strike movement; BIDU AAPL
Subscribe for More Information
09:39 EDTBIDUActive equity options trading on open
Subscribe for More Information
07:31 EDTBIDUChinaNet Online initiates O2O business project near Huaqiao University in China
Subscribe for More Information
06:38 EDTBIDU, SINAChina using new weapon to censor Internet content, NY Times says
China has deployed a new weapon in its effort to prevent Chinese citizens from viewing foreign websites of which Beijing does not approve, according to The New York Times. Dubbed The Great Cannon, the new weapon enables the government to intercept foreign web traffic flowing to Chinese websites, inject malicious code, and redirect the traffic, the newspaper stated, adding that the technology could easily be used to spy on all users who obtain content hosted on a Chinese computer. Chinese Internet stocks include Baidu (BIDU), SINA (SINA), Wiebo (WB), and Sohu.com (SOHU). Reference Link
April 9, 2015
17:46 EDTGALEGalena receives warning letter from FDA
Galena disclosed the following in a regulatory filing: "As previously reported by Galena Biopharma in its Annual Report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on March 5, following an inspection of our Portland, Oregon facility in November, the U.S. Food and Drug Administration issued a Form 483 Notice of Inspectional Observations noting deficiencies pertaining to post-marketing adverse drug experience reporting and current good manufacturing practices for Abstral and Zuplenz, our only approved products. We responded to the Form 483 Notice in a letter dated December 11, 2014. In conjunction with our response to the FDA, we initiated a number of programs and corrective actions to address the FDA's observations. On April 6, we received a Warning Letter from the FDA relating to certain of the matters originally identified in the Form 483 Notice. Specifically, the Warning Letter cites deficiencies in our response letter related to the adequacy of our written procedures for the surveillance, receipt, evaluation, and reporting of post-marketing adverse drug experiences from all sources, and the failure to report each adverse drug experience not reported under 21 CFR 314.80(c)(1)(i) at quarterly intervals."
16:00 EDTBIDUOptions Update; April 9, 2015
Subscribe for More Information
09:36 EDTBIDUActive equity options trading on open
Subscribe for More Information
08:00 EDTBIDUBaidu advertising boycott suspended by Putian Healthcare, Marbridge Daily says
Subscribe for More Information
April 8, 2015
09:35 EDTBIDUActive equity options trading on open
Subscribe for More Information
08:51 EDTBIDUHSBC expects Baidu and PHICC to reach an agreement shortly at HSBC
Subscribe for More Information
April 6, 2015
16:00 EDTBIDUOptions Update; April 6, 2015
iPath S&P 500 VIX Short-Term Futures down 51c to 24.53. Option volume leaders: AAPL TSLA VZ TWTR BIDU RIG NFLX AMZN KO PBR according to Track Data.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use